Condition
AD-MCI
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07672977Not ApplicableEnrolling By Invitation
Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study
NCT07643363Not ApplicableRecruiting
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment
NCT07512362Phase 2Recruiting
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
NCT06470074Not ApplicableNot Yet RecruitingPrimary
Clinical Multicenter Randomized Controlled Study of Non-invasive Brain Oscillation Modulation in the Treatment of AD-MCI Patients
Showing all 4 trials